Sfoglia per Autore
Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient
2022 Paccoud, O.; Alain, S.; Gozlan, J.; Jarboui, S.; Boutolleau, D.; Hantz, S.; Battipaglia, G.; Pavaglianiti, A.; Dulery, R.; Malard, F.; Mediavilla, C.; Sestili, S.; Gaugler, B.; Meynard, J. -L.; Pacanowski, J.; Mohty, M.; Brissot, E.
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
2022 Battipaglia, G.; Galimard, J. -E.; Labopin, M.; Raiola, A. M.; Blaise, D.; Ruggeri, A.; Koc, Y.; Gulbas, Z.; Vitek, A.; Sica, S.; Diez-Martin, J. L.; Castagna, L.; Bruno, B.; Rovira, M.; Moiseev, I.; Martino, M.; Grillo, G.; Araujo, M. C.; Bulabois, C. E.; Nguyen, S.; Socie, G.; Arat, M.; Pavlu, J.; Tischer, J.; Martin, H.; Corral, L. L.; Choi, G.; Forcade, E.; Mcdonald, A.; Pane, F.; Bazarbachi, A.; Ciceri, F.; Nagler, A.; Mohty, M.
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)
2021 Poiani, M.; Labopin, M.; Battipaglia, G.; Beelen, D. W.; Tischer, J.; Finke, J.; Brecht, A.; Forcade, E.; Ganser, A.; Passweg, J. R.; Labussiere-Wallet, H.; Yakoub-Agha, I.; Schafer-Eckart, K.; Kroeger, N.; Guffroy, B.; Ruggeri, A.; Esteve, J.; Nagler, A.; Mohty, M.
Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation
2021 Malard, F.; Lavelle, A.; Battipaglia, G.; Gaugler, B.; Dulery, R.; Brissot, E.; Mediavilla, C.; Jegou, S.; Rolhion, N.; Ledraa, T.; Mohty, R.; Sokol, H.; Mohty, M.
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
2021 Memoli, M.; Paviglianiti, A.; Malard, F.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Bianchessi, A.; Banet, A.; Van de Wyngaert, Z.; Ledraa, T.; Belhocine, R.; Sestili, S.; Lapusan, S.; Hirsch, P.; Favale, F.; Boussaroque, A.; Bonnin, A.; Vekhoff, A.; Legrand, O.; Mohty, M.; Dulery, R.
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
2021 Battipaglia, G.; Mauff, K.; Wendel, L.; Angelucci, E.; Mohty, M.; Arcese, W.; Santarone, S.; Rubio, M. T.; Kroger, N.; Fox, M. L.; Blaise, D.; Iori, A. P.; Fanin, R.; Chalandon, Y.; Pioltelli, P.; Marotta, G.; Chiusolo, P.; Sever, M.; Solano, C.; Contentin, N.; de Wreede, L. C.; Czerw, T.; Hernandez-Boluda, J. C.; Hayden, P.; Mclornan, D.; Yakoub-Agha, I.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2021 Battipaglia, G.; Labopin, M.; Hamladji, R. -M.; Blaise, D.; Chevallier, P.; Brissot, E.; Gerbitz, A.; Socie, G.; Afanasyev, B.; Ciceri, F.; Meijer, E.; Koc, Y.; Cornelissen, J. J.; Huynh, A.; Ozdogu, H.; Maertens, J.; Paul, F.; Labussiere-Wallet, H.; Ruggeri, A.; Aljurf, M.; Bazarbachi, A.; Savani, B.; Nagler, A.; Mohty, M.
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation
2021 Dulery, R.; Mohty, R.; Labopin, M.; Sestili, S.; Malard, F.; Brissot, E.; Battipaglia, G.; Mediavilla, C.; Banet, A.; Van de Wyngaert, Z.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Cohen, A.; Bonnin, A.; Ederhy, S.; Mohty, M.
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2020 Ruggeri, A.; Labopin, M.; Battipaglia, G.; Chiusolo, P.; Tischer, J.; Diez-Martin, J. L.; Bruno, B.; Castagna, L.; Moiseev, I. S.; Vitek, A.; Rovira, M.; Ciceri, F.; Bacigalupo, A.; Nagler, A.; Mohty, M.
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft
2020 Stocker, N.; Gaugler, B.; Labopin, M.; Farge, A.; Ye, Y.; Ricard, L.; Brissot, E.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Banet, A.; Van De Wyngaert, Z.; Ledraa, T.; Mohty, M.; Malard, F.
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center experience
2020 Sestili, S.; Eder, S.; Belhocine, R.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Banet, A.; van de Wyngaert, Z.; Paviglianiti, A.; Ledraa, T.; Bonin, A.; Mohty, M.; Malard, F.
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies
2020 Peric, Z.; Mohty, R.; Bastos, J.; Brissot, E.; Battipaglia, G.; Belhocine, R.; Sestili, S.; Giannotti, F.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Lapusan, S.; Isnard, F.; Labopin, M.; Bonnin, A.; Mediavilla, C.; Rubio, M. -T.; Ruggeri, A.; Dulery, R.; Malard, F.; Mohty, M.
Transmission of Legionnaires' Disease through Toilet Flushing
2020 Couturier, J.; Ginevra, C.; Nesa, D.; Adam, M.; Gouot, C.; Descours, G.; Campese, C.; Battipaglia, G.; Brissot, E.; Beraud, L.; Ranc, A. -G.; Jarraud, S.; Barbut, F.
Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes
2020 Stocker, N.; Labopin, M.; Boussen, I.; Paccoud, O.; Bonnin, A.; Malard, F.; Amiel, C.; Gozlan, J.; Battipaglia, G.; Dulery, R.; Giannotti, F.; Ruggeri, A.; Gaugler, B.; Mohty, M.; Brissot, E.
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
2020 Paccoud, O.; Guitard, J.; Labopin, M.; Surgers, L.; Malard, F.; Battipaglia, G.; Dulery, R.; Hennequin, C.; Mohty, M.; Brissot, E.
Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group
2020 Polomeni, A.; Bompoint, C.; Labopin, M.; Badoglio, M.; Battipaglia, G.; Eeltink, C.; Liptrott, S. J.; Babik, A.; Murray, J.; Stringer, J.
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
2020 Debureaux, P. -E.; Labopin, M.; Mamez, A. -C.; Lapusan, S.; Isnard, F.; Adaeva, R.; Bonnin, A.; Hirsch, P.; Delhommeau, F.; Battipaglia, G.; Dulery, R.; Malard, F.; Vekhoff, A.; Mohty, M.; Legrand, O.; Brissot, E.
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
2020 Marini, C.; Brissot, E.; Bazarbachi, A.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Bannet, A.; van de Wiegert, Z.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Labopin, M.; Bonnin, A.; Ruggeri, A.; Malard, F.; Mohty, M.
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients
2020 Polverelli, N.; Tura, P.; Battipaglia, G.; Malagola, M.; Bernardi, S.; Gandolfi, L.; Zollner, T.; Zanaglio, C.; Farina, M.; Morello, E.; Turra, A.; Mohty, M.; Russo, D.
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study
2019 Bazarbachi, Ali; Labopin, Myriam; Battipaglia, Giorgia; Djabali, Azedine; Forcade, Edouard; Arcese, William; Socié, Gerard; Blaise, Didier; Halter, Joerg; Gerull, Sabine; Cornelissen, Jan J; Chevallier, Patrice; Maertens, Johan; Schaap, Nicolaas; El-Cheikh, Jean; Esteve, Jordi; Nagler, Arnon; Mohty, Mohamad
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient | 1.1 Articolo in rivista | 2022 | Paccoud, O.; Alain, S.; Gozlan, J.; Jarboui, S.; Boutolleau, D.; Hantz, S.; Battipaglia, G.; Pavaglianiti, A.; Dulery, R.; Malard, F.; Mediavilla, C.; Sestili, S.; Gaugler, B.; Meynard, J. -L.; Pacanowski, J.; Mohty, M.; Brissot, E. | |
| Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT | 1.1 Articolo in rivista | 2022 | Battipaglia, G.; Galimard, J. -E.; Labopin, M.; Raiola, A. M.; Blaise, D.; Ruggeri, A.; Koc, Y.; Gulbas, Z.; Vitek, A.; Sica, S.; Diez-Martin, J. L.; Castagna, L.; Bruno, B.; Rovira, M.; Moiseev, I.; Martino, M.; Grillo, G.; Araujo, M. C.; Bulabois, C. E.; Nguyen, S.; Socie, G.; Arat, M.; Pavlu, J.; Tischer, J.; Martin, H.; Corral, L. L.; Choi, G.; Forcade, E.; Mcdonald, A.; Pane, F.; Bazarbachi, A.; Ciceri, F.; Nagler, A.; Mohty, M. | |
| The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT) | 1.1 Articolo in rivista | 2021 | Poiani, M.; Labopin, M.; Battipaglia, G.; Beelen, D. W.; Tischer, J.; Finke, J.; Brecht, A.; Forcade, E.; Ganser, A.; Passweg, J. R.; Labussiere-Wallet, H.; Yakoub-Agha, I.; Schafer-Eckart, K.; Kroeger, N.; Guffroy, B.; Ruggeri, A.; Esteve, J.; Nagler, A.; Mohty, M. | |
| Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation | 1.1 Articolo in rivista | 2021 | Malard, F.; Lavelle, A.; Battipaglia, G.; Gaugler, B.; Dulery, R.; Brissot, E.; Mediavilla, C.; Jegou, S.; Rolhion, N.; Ledraa, T.; Mohty, R.; Sokol, H.; Mohty, M. | |
| Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience | 1.1 Articolo in rivista | 2021 | Memoli, M.; Paviglianiti, A.; Malard, F.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Bianchessi, A.; Banet, A.; Van de Wyngaert, Z.; Ledraa, T.; Belhocine, R.; Sestili, S.; Lapusan, S.; Hirsch, P.; Favale, F.; Boussaroque, A.; Bonnin, A.; Vekhoff, A.; Legrand, O.; Mohty, M.; Dulery, R. | |
| Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT | 1.1 Articolo in rivista | 2021 | Battipaglia, G.; Mauff, K.; Wendel, L.; Angelucci, E.; Mohty, M.; Arcese, W.; Santarone, S.; Rubio, M. T.; Kroger, N.; Fox, M. L.; Blaise, D.; Iori, A. P.; Fanin, R.; Chalandon, Y.; Pioltelli, P.; Marotta, G.; Chiusolo, P.; Sever, M.; Solano, C.; Contentin, N.; de Wreede, L. C.; Czerw, T.; Hernandez-Boluda, J. C.; Hayden, P.; Mclornan, D.; Yakoub-Agha, I. | |
| Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | 1.1 Articolo in rivista | 2021 | Battipaglia, G.; Labopin, M.; Hamladji, R. -M.; Blaise, D.; Chevallier, P.; Brissot, E.; Gerbitz, A.; Socie, G.; Afanasyev, B.; Ciceri, F.; Meijer, E.; Koc, Y.; Cornelissen, J. J.; Huynh, A.; Ozdogu, H.; Maertens, J.; Paul, F.; Labussiere-Wallet, H.; Ruggeri, A.; Aljurf, M.; Bazarbachi, A.; Savani, B.; Nagler, A.; Mohty, M. | |
| Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation | 1.1 Articolo in rivista | 2021 | Dulery, R.; Mohty, R.; Labopin, M.; Sestili, S.; Malard, F.; Brissot, E.; Battipaglia, G.; Mediavilla, C.; Banet, A.; Van de Wyngaert, Z.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Cohen, A.; Bonnin, A.; Ederhy, S.; Mohty, M. | |
| Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | 1.1 Articolo in rivista | 2020 | Ruggeri, A.; Labopin, M.; Battipaglia, G.; Chiusolo, P.; Tischer, J.; Diez-Martin, J. L.; Bruno, B.; Castagna, L.; Moiseev, I. S.; Vitek, A.; Rovira, M.; Ciceri, F.; Bacigalupo, A.; Nagler, A.; Mohty, M. | |
| High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft | 1.1 Articolo in rivista | 2020 | Stocker, N.; Gaugler, B.; Labopin, M.; Farge, A.; Ye, Y.; Ricard, L.; Brissot, E.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Banet, A.; Van De Wyngaert, Z.; Ledraa, T.; Mohty, M.; Malard, F. | |
| Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center experience | 1.1 Articolo in rivista | 2020 | Sestili, S.; Eder, S.; Belhocine, R.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Banet, A.; van de Wyngaert, Z.; Paviglianiti, A.; Ledraa, T.; Bonin, A.; Mohty, M.; Malard, F. | |
| Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies | 1.1 Articolo in rivista | 2020 | Peric, Z.; Mohty, R.; Bastos, J.; Brissot, E.; Battipaglia, G.; Belhocine, R.; Sestili, S.; Giannotti, F.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Lapusan, S.; Isnard, F.; Labopin, M.; Bonnin, A.; Mediavilla, C.; Rubio, M. -T.; Ruggeri, A.; Dulery, R.; Malard, F.; Mohty, M. | |
| Transmission of Legionnaires' Disease through Toilet Flushing | 1.1 Articolo in rivista | 2020 | Couturier, J.; Ginevra, C.; Nesa, D.; Adam, M.; Gouot, C.; Descours, G.; Campese, C.; Battipaglia, G.; Brissot, E.; Beraud, L.; Ranc, A. -G.; Jarraud, S.; Barbut, F. | |
| Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes | 1.1 Articolo in rivista | 2020 | Stocker, N.; Labopin, M.; Boussen, I.; Paccoud, O.; Bonnin, A.; Malard, F.; Amiel, C.; Gozlan, J.; Battipaglia, G.; Dulery, R.; Giannotti, F.; Ruggeri, A.; Gaugler, B.; Mohty, M.; Brissot, E. | |
| Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting | 1.1 Articolo in rivista | 2020 | Paccoud, O.; Guitard, J.; Labopin, M.; Surgers, L.; Malard, F.; Battipaglia, G.; Dulery, R.; Hennequin, C.; Mohty, M.; Brissot, E. | |
| Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group | 1.1 Articolo in rivista | 2020 | Polomeni, A.; Bompoint, C.; Labopin, M.; Badoglio, M.; Battipaglia, G.; Eeltink, C.; Liptrott, S. J.; Babik, A.; Murray, J.; Stringer, J. | |
| Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia | 1.1 Articolo in rivista | 2020 | Debureaux, P. -E.; Labopin, M.; Mamez, A. -C.; Lapusan, S.; Isnard, F.; Adaeva, R.; Bonnin, A.; Hirsch, P.; Delhommeau, F.; Battipaglia, G.; Dulery, R.; Malard, F.; Vekhoff, A.; Mohty, M.; Legrand, O.; Brissot, E. | |
| Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation | 1.1 Articolo in rivista | 2020 | Marini, C.; Brissot, E.; Bazarbachi, A.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Bannet, A.; van de Wiegert, Z.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Labopin, M.; Bonnin, A.; Ruggeri, A.; Malard, F.; Mohty, M. | |
| Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients | 1.1 Articolo in rivista | 2020 | Polverelli, N.; Tura, P.; Battipaglia, G.; Malagola, M.; Bernardi, S.; Gandolfi, L.; Zollner, T.; Zanaglio, C.; Farina, M.; Morello, E.; Turra, A.; Mohty, M.; Russo, D. | |
| Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study | 1.1 Articolo in rivista | 2019 | Bazarbachi, Ali; Labopin, Myriam; Battipaglia, Giorgia; Djabali, Azedine; Forcade, Edouard; Arcese, William; Socié, Gerard; Blaise, Didier; Halter, Joerg; Gerull, Sabine; Cornelissen, Jan J; Chevallier, Patrice; Maertens, Johan; Schaap, Nicolaas; El-Cheikh, Jean; Esteve, Jordi; Nagler, Arnon; Mohty, Mohamad |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile